Catalina Valencia - 15 Mar 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
10%+ Owner
Signature
/s/ Catalina Valencia
Issuer symbol
AXIM
Transactions as of
15 Mar 2024
Net transactions value
+$1,228,528,125,000
Form type
4
Filing time
19 Mar 2024, 19:39:54 UTC
Previous filing
15 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $1,228,528,125,000 +7,837,500 $156750.00* 7,837,500 15 Mar 2024 Common Stock 7,837,500 $0.0200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a convertible note, face value $156,750. The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares..